FDA Green Lights Zykadia in NSCLC

Published April 29, 2014

FDA Green Lights Zykadia in NSCLC
"It also demonstrates the FDA's commitment to working cooperatively with companies to expedite a drug's development, review, and approval, reflecting the promise of the breakthrough therapy-designation program." Ceritinib won the breakthrough-therapy …
Read more on MedPage Today

Biotech to the Rescue
Combine the rise of anti-angiogenesis with Sasisekharan's wife's career as an oncologist — “who inspired me to focus on cancer treatment,” he says — and you have the ingredients for the scientific core of Cerulean. Building on groundwork laid by …
Read more on MIT Technology Review

Congressional panel votes to subpoena Richard Cordray's aides in …
He has ordered an internal review. … The discrimination issue has been playing out since an April 2 subcommittee hearing in which the fledgling CFPB was accused of giving white men favorable treatment at the expense of black employees and women.
Read more on The Plain Dealer

Find More Drug Rehab Reviews Information…